IN2012DN03632A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03632A IN2012DN03632A IN3632DEN2012A IN2012DN03632A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A IN 3632DEN2012 A IN3632DEN2012 A IN 3632DEN2012A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A
- Authority
- IN
- India
- Prior art keywords
- weight
- amount
- fos
- present
- inulin
- Prior art date
Links
- 229920001202 Inulin Polymers 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
- 229940029339 inulin Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 229920000189 Arabinogalactan Polymers 0.000 abstract 1
- 239000001904 Arabinogalactan Substances 0.000 abstract 1
- 229920002907 Guar gum Polymers 0.000 abstract 1
- 235000019312 arabinogalactan Nutrition 0.000 abstract 1
- 239000000665 guar gum Substances 0.000 abstract 1
- 229960002154 guar gum Drugs 0.000 abstract 1
- 235000010417 guar gum Nutrition 0.000 abstract 1
- 244000005709 gut microbiome Species 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Pediatric Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
Abstract
The present disclosure relates to nutritional compositions comprising a fructo-oligosaccharaide (FOS) in an amount of 35 to 44% by weight; a polysaccharide that is not a partially hydrolyzed guar gum such as, for example, an arabinogalactan in an amount of 50% to 38% by weight; and inulin in an amount of 12% to 24% by weight. The FOS and the polysaccharide may be present in a weight ratio of about 1:1. More specifically, the FOS and inulin may be present in a weight ratio of about 7:3. Also provided are methods of promoting gut microbiota balance and health. The methods include administering an effective amount of the nutritional composition to patients in need of same.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26049509P | 2009-11-12 | 2009-11-12 | |
| US26443009P | 2009-11-25 | 2009-11-25 | |
| US39480510P | 2010-10-20 | 2010-10-20 | |
| PCT/US2010/056321 WO2011060123A1 (en) | 2009-11-12 | 2010-11-11 | Nutritional composition for promoting gut microbiota balance and health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03632A true IN2012DN03632A (en) | 2015-06-26 |
Family
ID=43567734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3632DEN2012 IN2012DN03632A (en) | 2009-11-12 | 2010-11-11 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9192179B2 (en) |
| EP (1) | EP2498626B1 (en) |
| JP (2) | JP6006117B2 (en) |
| CN (2) | CN102595934A (en) |
| AU (1) | AU2010319490B2 (en) |
| BR (1) | BR112012011294B1 (en) |
| CA (1) | CA2777941C (en) |
| DK (1) | DK2498626T3 (en) |
| ES (1) | ES2545597T3 (en) |
| IN (1) | IN2012DN03632A (en) |
| MX (1) | MX336032B (en) |
| PH (1) | PH12012500687A1 (en) |
| RU (1) | RU2012123959A (en) |
| WO (1) | WO2011060123A1 (en) |
Families Citing this family (95)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011060123A1 (en) * | 2009-11-12 | 2011-05-19 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
| MY191538A (en) * | 2010-12-31 | 2022-06-30 | Abbott Lab | Human milk oligosaccharides to promote growth of beneficial bacteria |
| DK2734049T3 (en) | 2011-06-20 | 2018-07-30 | Heinz Co Brands H J Llc | PROBIOTIC COMPOSITIONS AND PROCEDURES |
| WO2012175639A1 (en) * | 2011-06-22 | 2012-12-27 | Universite De Rouen | Arabinogalactan proteins for use as an antiparasitic agent |
| FI126711B (en) * | 2011-10-12 | 2017-04-13 | Gut Guide Oy | Assessing the health risk associated with a serotonin deficiency |
| CN103889241B (en) | 2011-10-18 | 2016-08-17 | 雀巢产品技术援助有限公司 | For sanatory osteogenesis and/or for preventing and/or treat the compositions of osteopathia |
| TW201318566A (en) * | 2011-11-01 | 2013-05-16 | 呂健民 | Dietary supplement composition and method for regulating blood sugar thereof |
| EP2836224A4 (en) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | MICROBIOTA COMPOSITIONS AND ASSOCIATED METHODS |
| ITRM20120084A1 (en) | 2012-03-07 | 2013-09-08 | Aboca Spa Societa Agricola | PREBIOTIC MIXTURE. |
| WO2014007606A1 (en) | 2012-07-05 | 2014-01-09 | N.V. Nutricia | Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour |
| BR112015009975A2 (en) * | 2012-11-01 | 2017-07-11 | Academisch Ziekenhuis Groningen | methods and compositions for the stimulation of beneficial bacteria in the gastrointestinal tract |
| US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| SG11201503966PA (en) | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US20150296851A1 (en) * | 2012-11-27 | 2015-10-22 | Shanghai Jiao Tong University | Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof |
| JP2016509003A (en) * | 2013-02-04 | 2016-03-24 | セレス セラピューティクス インコーポレイテッド | Compositions and methods |
| US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
| EP2983662A4 (en) * | 2013-03-15 | 2016-09-21 | MicroBiome Therapeutics LLC | ACTIVE SOY FIBER |
| GB201312713D0 (en) * | 2013-03-22 | 2013-08-28 | Weaver Connie M | Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption |
| GB201305708D0 (en) * | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
| CA2945184A1 (en) * | 2013-04-11 | 2014-10-16 | Bright Drinks Inc. | Compositions for prevention and/or treatment of gastrointestinal imbalances in digestive disorders |
| ITMI20131467A1 (en) * | 2013-09-06 | 2015-03-07 | Sofar Spa | USE OF A COMPOSITION INCLUDING MICRO-ORGANISMS TO INCREASE THE INTESTINAL PRODUCTION OF BUTIRRIC ACID, FOLIC ACID OR NIACINE ACID AND / OR TO REDUCE THE INTESTINAL PRODUCTION OF SUCCINIC ACID |
| CN105979952B (en) | 2013-11-25 | 2022-04-08 | 赛里斯治疗公司 | Synergistic bacterial composition and method of manufacture and use thereof |
| US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
| CN117770454A (en) * | 2013-12-20 | 2024-03-29 | 雀巢产品有限公司 | Nutritional composition for reducing intestinal pathogens |
| MA39710A (en) | 2014-04-23 | 2015-10-29 | Sofar Spa | Topical composition for use in the treatment of inflammatory bowel disease |
| CN104187624B (en) * | 2014-08-07 | 2016-06-08 | 逯明福 | Comprehensive nutrition powder and its preparation method |
| WO2016029113A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate |
| MX382504B (en) | 2014-09-30 | 2025-03-13 | Kimberly Clark Co | PREBIOTIC CREPETED TISSUE PAPER. |
| BR112017004630B1 (en) | 2014-09-30 | 2023-04-11 | Kimberly-Clark Worldwide, Inc | SYNERGIC PREBIOTICS FORMULATION, PREBIOTICS WAND, AND PREBIOTICS WEET WAND |
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| CN104432069A (en) * | 2014-12-22 | 2015-03-25 | 威海百合生物技术股份有限公司 | Gastrointestinal smoothening tablets |
| JP6338113B2 (en) * | 2015-03-31 | 2018-06-06 | 株式会社東洋新薬 | Lean body weight increase agent |
| JP6861708B2 (en) * | 2015-12-30 | 2021-04-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | A method for measuring lean body mass |
| JP2019501157A (en) * | 2015-12-31 | 2019-01-17 | ネステク ソシエテ アノニム | Composition for improving mouthfeel |
| EP3639834B1 (en) * | 2016-02-04 | 2023-07-12 | Universiteit Gent | Use of microbial communities for human and animal health |
| EP4302824A3 (en) | 2016-04-20 | 2024-03-20 | The Board of Trustees of the Leland Stanford Junior University | Compositions and methods for nucleic acid expression and protein secretion in bacteroides |
| IT201600083376A1 (en) | 2016-08-08 | 2018-02-08 | Sofar Spa | Use of probiotics to increase protein absorption |
| ITUA20164188A1 (en) | 2016-06-08 | 2017-12-08 | Sofar Spa | New medical use of probiotics |
| US20180030403A1 (en) | 2016-07-28 | 2018-02-01 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
| US20200016256A1 (en) * | 2016-09-22 | 2020-01-16 | The University Of Chicago | Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization |
| IT201600122724A1 (en) | 2016-12-02 | 2018-06-02 | Sofar Spa | EXOPOLYSACCHARIDES AND USES THEREOF |
| US11566238B2 (en) | 2016-12-15 | 2023-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
| IT201600127498A1 (en) | 2016-12-16 | 2018-06-16 | Sofar Spa | PROBIOTICS FOR USE IN DIVERTICULOSIS AND DIVERTICULAR DISEASE |
| CN108245530A (en) * | 2016-12-28 | 2018-07-06 | 兰州奇正生态健康品有限公司 | A kind of composition with functions of loosening bowel relieving constipation and preparation method thereof and purposes |
| ES2683014B1 (en) * | 2017-03-23 | 2019-01-16 | Cuetara S L | Child cookie without added sugars |
| RU2765232C1 (en) | 2017-06-21 | 2022-01-26 | Эбботт Лабораториз | Method for improving the growth of beneficial bacteria in the gastrointestinal tract |
| EP3668527A1 (en) | 2017-08-14 | 2020-06-24 | Seres Therapeutics, Inc. | Compositions and methods for treating cholestatic disease |
| JP2020532515A (en) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | Methods and compositions for the treatment of microbiome-related disorders |
| GB2566971B (en) * | 2017-09-28 | 2020-12-02 | Mjn Us Holdings Llc | Infant formula having decreased protein content |
| IT201700108033A1 (en) * | 2017-09-27 | 2019-03-27 | Neilos S R L | Composition for the treatment of constipation |
| IT201700108039A1 (en) * | 2017-09-27 | 2019-03-27 | Neilos S R L | Composition for the treatment of constipation |
| EP3466276A1 (en) | 2017-10-05 | 2019-04-10 | Pharmactive Biotech Products, S.L. | Dietary fiber composition for protecting bioactive compounds during the physiological digestion process |
| BR112020008552A2 (en) | 2017-10-30 | 2020-12-29 | Seres Therapeutics, Inc. | methods and compositions for treating antibiotic resistance |
| US20200261516A1 (en) * | 2017-10-31 | 2020-08-20 | Morinaga Milk Industry Co., Ltd. | Composition for Increasing Muscle Mass |
| US11484547B2 (en) * | 2018-01-08 | 2022-11-01 | Performance Labs PTE. LTD. | Compositions and methods for cholesterol, glucose and microbiome control |
| EP3823651A4 (en) | 2018-07-19 | 2022-04-27 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MICROBIAL GRAFT |
| US20200113858A1 (en) | 2018-10-15 | 2020-04-16 | Freedom Health, Llc | Human dietary supplement and method for treating digestive system and immune-related disorders |
| AU2019410086B2 (en) * | 2018-12-19 | 2025-04-17 | Cosucra Groupe Warcoing S.A. | Composition comprising chicory root and pea cell wall fiber for treating Brachyspira infections |
| US11622974B2 (en) * | 2019-01-18 | 2023-04-11 | C.P. Kelco U.S., Inc. | Prebiotic composition and its use |
| WO2020161522A1 (en) * | 2019-02-06 | 2020-08-13 | Thd S.P.A. | Fiber-based composition |
| FR3093427B1 (en) * | 2019-03-05 | 2021-03-05 | Mativa Tech | COMPOSITION FOR USE IN THE PREVENTION AND / OR TREATMENT OF DYSBIOSIS |
| WO2020185857A1 (en) * | 2019-03-12 | 2020-09-17 | The Board Of Regents Of The University Of Texas System | Simultaneous blood glucose monitoring and gastric emptying scintigraphy |
| CN109820865A (en) * | 2019-04-09 | 2019-05-31 | 福州大学 | Application of xylo-oligosaccharide and partially hydrolyzed guar gum compound composition in obesity prevention and health care products |
| JP7321503B2 (en) * | 2019-05-21 | 2023-08-07 | フジ日本精糖株式会社 | Inulin-containing muscle mass decrease inhibitor or bone density decrease inhibitor |
| US20220248739A1 (en) | 2019-05-29 | 2022-08-11 | N.V. Nutricia | Non-digestible oligosaccharides for decreased colonic protein fermentation |
| CN114366826A (en) * | 2019-07-09 | 2022-04-19 | 大连大学 | Preparation method of larch arabinogalactan composition and sterilization treatment device thereof |
| MY197412A (en) * | 2019-08-30 | 2023-06-16 | Hem Pharma Inc | Method for screening personalized intestinal environment-improving material and composition therefor |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| CN110679955A (en) * | 2019-11-11 | 2020-01-14 | 成都高新区九州华昀医疗美容门诊部有限公司 | Giant salamander active peptide nutritional composition capable of improving intestinal function |
| US20230110977A1 (en) * | 2020-02-27 | 2023-04-13 | Abbott Laboratories | Methods of improving bone health |
| WO2021214292A1 (en) * | 2020-04-24 | 2021-10-28 | Société des Produits Nestlé S.A. | Composition comprising fibre and mulberry |
| CN111440841A (en) * | 2020-05-19 | 2020-07-24 | 爱礼康生物医药（苏州）有限公司 | Method for detecting influence of dietary fiber on activity of human intestinal bacteria |
| EP4152961A1 (en) * | 2020-05-20 | 2023-03-29 | Société des Produits Nestlé S.A. | Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum |
| AU2021281622A1 (en) * | 2020-05-29 | 2022-12-01 | Societe Des Produits Nestle Sa | Compositions and methods for digestive health in an animal |
| JP7688866B2 (en) * | 2020-07-14 | 2025-06-05 | 物産フードサイエンス株式会社 | Agent and method for increasing muscle mass percentage, and agent and method for decreasing body fat percentage |
| WO2022083858A1 (en) * | 2020-10-21 | 2022-04-28 | Compagnie Gervais Danone | Acacia gum for iron induced microbial dysbiosis |
| JP2022072243A (en) * | 2020-10-29 | 2022-05-17 | 帝人株式会社 | Composition for improving intestinal bacterial flora, and composition for inhibiting production of intestinal putrefactive substance |
| CN112715669A (en) * | 2020-11-24 | 2021-04-30 | 本溪木兰花乳业有限责任公司 | Milk product for improving constipation and preparation method thereof |
| CN116615116A (en) | 2020-12-09 | 2023-08-18 | N·V·努特里奇亚 | Fiber mixture for infants |
| EP4119135A1 (en) * | 2021-07-13 | 2023-01-18 | Luxia Scientific | Methods for rebalancing the intestinal flora in patients suffering from parkinson's disease |
| WO2023288041A1 (en) * | 2021-07-16 | 2023-01-19 | Purdue Research Foundation | Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut |
| CN113826892A (en) * | 2021-09-17 | 2021-12-24 | 潍坊易北特健康食品有限公司 | Composition for regulating and controlling specific bile acid based on intestinal microorganisms and preparation method |
| WO2023054625A1 (en) * | 2021-09-29 | 2023-04-06 | 森永乳業株式会社 | Threonic-acid-containing composition and method for producing same |
| JP2023055389A (en) * | 2021-10-06 | 2023-04-18 | 株式会社明治 | Proliferation promoting agents for bacteria belonging to the genus bacteroides |
| CN114224925A (en) * | 2021-12-23 | 2022-03-25 | 广东格物生物科技有限公司 | Probiotic composition for regulating intestinal health and preparation method thereof |
| ES2955633A1 (en) * | 2022-04-26 | 2023-12-04 | Servicio Andaluz De Salud | Composition for intestinal rehabilitation |
| CN115025116B (en) * | 2022-07-13 | 2023-11-21 | 纽湃腾（北京）医药科技有限公司 | Composition for remarkably improving gastroesophageal reflux and irritable bowel syndrome and application thereof |
| WO2025106584A1 (en) * | 2023-11-14 | 2025-05-22 | Kate Farms, Inc. | Infant formula |
| GR1011003B (en) * | 2024-02-28 | 2025-07-22 | Cloudpharm Private Company, | Nutritional supplement for treating bone density loss - osteopenia |
| WO2025262090A1 (en) * | 2024-06-18 | 2025-12-26 | Dsm Ip Assets B.V. | Combination of carotenoids and inulin and uses thereof |
| CN118681027A (en) * | 2024-07-16 | 2024-09-24 | 广州医科大学附属第一医院（广州呼吸中心） | A kind of butyrate inulin gel and preparation method thereof |
| US20260083772A1 (en) * | 2024-09-26 | 2026-03-26 | Kenvue Brands Llc | Powder compositions comprising fiber |
| CN121286706A (en) * | 2025-12-01 | 2026-01-09 | 仙乐健康科技股份有限公司 | Compositions, nutritional compositions, and uses for adjusting gut microbiota |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952314A (en) | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
| DE69506095T2 (en) | 1995-08-04 | 1999-06-24 | Naamloze Vennootschap Nutricia, Zoetermeer | Dietary composition containing dietary fibers |
| DE69832182T2 (en) * | 1998-12-15 | 2006-07-20 | Société des Produits Nestlé S.A. | Fiber mixture for enteral composition |
| HUP0204546A3 (en) * | 2000-03-01 | 2003-10-28 | Nestle Sa | Carbohydrate formulation for enhancement of immune response |
| EP1175905A1 (en) | 2000-07-24 | 2002-01-30 | Societe Des Produits Nestle S.A. | Nutritional Composition |
| US6592863B2 (en) | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
| EP1243273A1 (en) * | 2001-03-22 | 2002-09-25 | Societe Des Produits Nestle S.A. | Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters |
| GB0308104D0 (en) | 2003-04-08 | 2003-05-14 | Novartis Nutrition Ag | Organic compounds |
| ITMI20040956A1 (en) * | 2004-05-12 | 2004-08-12 | Curti Alessandro | FOOD COMPOSITIONS |
| EP1597978A1 (en) | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
| US8252769B2 (en) | 2004-06-22 | 2012-08-28 | N. V. Nutricia | Intestinal barrier integrity |
| CN101299934B (en) * | 2005-10-05 | 2012-08-08 | 雀巢技术公司 | Nutritional formulation for promoting catch-up growth |
| ITMI20062031A1 (en) | 2006-10-23 | 2008-04-24 | Velleja Res Srl | COMPOSITIONS FOR THE PREVENTION OF DEPAUPERAMENTO OF THE INTESTINAL FLORA AND OF THE DAMAGE OF ORGAN SUBSEQUENT TO ANTIBIOTIC THERAPY |
| IN2014DN03102A (en) | 2006-11-07 | 2015-07-10 | Procter & Gamble | |
| ITMI20071214A1 (en) * | 2007-06-15 | 2008-12-16 | S I I T Srl Servizio Internazi | COMPOSITIONS BASED ON PREBIOTIC AND IMMUNOGENIC COMPONENTS FOR THE PREVENTION AND TREATMENT OF GASTROENTERIC DISORDERS FROM DISBIOSIS AND / OR ALTERATIONS OF THE NORMAL INTESTINAL FLORA |
| ES2392002T5 (en) | 2007-07-18 | 2022-04-07 | Frieslandcampina Nederland Bv | Thermostable nutritious drink and method for preparing it |
| WO2009075564A1 (en) | 2007-12-10 | 2009-06-18 | N.V. Nutricia | Paediatric fibre mixture |
| JP5992654B2 (en) | 2007-12-21 | 2016-09-14 | ニュートリー株式会社 | Composition for intestinal regulation and / or improvement of bowel movement |
| WO2011060123A1 (en) * | 2009-11-12 | 2011-05-19 | Nestec S.A. | Nutritional composition for promoting gut microbiota balance and health |
-
2010
- 2010-11-11 WO PCT/US2010/056321 patent/WO2011060123A1/en not_active Ceased
- 2010-11-11 CN CN2010800498229A patent/CN102595934A/en active Pending
- 2010-11-11 AU AU2010319490A patent/AU2010319490B2/en active Active
- 2010-11-11 PH PH1/2012/500687A patent/PH12012500687A1/en unknown
- 2010-11-11 MX MX2012004778A patent/MX336032B/en unknown
- 2010-11-11 EP EP10779417.4A patent/EP2498626B1/en not_active Revoked
- 2010-11-11 IN IN3632DEN2012 patent/IN2012DN03632A/en unknown
- 2010-11-11 ES ES10779417.4T patent/ES2545597T3/en active Active
- 2010-11-11 US US13/502,918 patent/US9192179B2/en active Active
- 2010-11-11 DK DK10779417.4T patent/DK2498626T3/en active
- 2010-11-11 CA CA2777941A patent/CA2777941C/en active Active
- 2010-11-11 JP JP2012538966A patent/JP6006117B2/en active Active
- 2010-11-11 RU RU2012123959/13A patent/RU2012123959A/en not_active Application Discontinuation
- 2010-11-11 CN CN201410364998.3A patent/CN104206946A/en active Pending
- 2010-11-11 BR BR112012011294-5A patent/BR112012011294B1/en active IP Right Grant
-
2015
- 2015-10-20 US US14/887,497 patent/US10015978B2/en active Active
-
2016
- 2016-02-15 JP JP2016025895A patent/JP6205003B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PH12012500687A1 (en) | 2012-10-29 |
| ES2545597T3 (en) | 2015-09-14 |
| US20160100617A1 (en) | 2016-04-14 |
| EP2498626A1 (en) | 2012-09-19 |
| CN104206946A (en) | 2014-12-17 |
| JP6006117B2 (en) | 2016-10-12 |
| JP6205003B2 (en) | 2017-09-27 |
| AU2010319490A1 (en) | 2012-05-03 |
| CN102595934A (en) | 2012-07-18 |
| US9192179B2 (en) | 2015-11-24 |
| DK2498626T3 (en) | 2015-07-13 |
| BR112012011294A2 (en) | 2015-09-15 |
| JP2013510865A (en) | 2013-03-28 |
| WO2011060123A1 (en) | 2011-05-19 |
| US10015978B2 (en) | 2018-07-10 |
| AU2010319490B2 (en) | 2015-03-19 |
| US20120269865A1 (en) | 2012-10-25 |
| HK1172516A1 (en) | 2013-04-26 |
| CA2777941A1 (en) | 2011-05-19 |
| EP2498626B1 (en) | 2015-06-17 |
| JP2016166176A (en) | 2016-09-15 |
| MX2012004778A (en) | 2012-06-01 |
| BR112012011294B1 (en) | 2018-03-20 |
| CA2777941C (en) | 2018-08-14 |
| MX336032B (en) | 2016-01-07 |
| RU2012123959A (en) | 2013-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03632A (en) | ||
| NZ602249A (en) | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders | |
| MY148405A (en) | Immunogenic composition | |
| WO2006110406A3 (en) | Compositions comprising probiotic and sweetener components | |
| MX2010005424A (en) | Particulate coating processing. | |
| WO2011056487A3 (en) | Stable thickener formulations | |
| TNSN07360A1 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
| MX2015006971A (en) | Pseudo-loaf food compositions. | |
| MY158319A (en) | Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid | |
| MX2011012297A (en) | The improvement of gastrointestinal health, immunity and performance by dietary intervention. | |
| PH12012502159A1 (en) | Pharmaceutical compositions and methods of making same | |
| MX2010004195A (en) | Trans-clomiphene for metabolic syndrome. | |
| MX2019012939A (en) | Linaclotide-containing formulations for oral administration. | |
| MX351037B (en) | Mouth-moistening gum compositions and products containing the same. | |
| PT2197456E (en) | Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid | |
| NZ605147A (en) | Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations | |
| HRP20171861T1 (en) | Dermatological compositions comprising heparan sulfate | |
| WO2008073764A3 (en) | Substantially pure fluorescein | |
| MY175195A (en) | Nutritional compositions | |
| HRP20231090T1 (en) | PREPARATIONS AND METHODS OF SYNERGISTIC TREATMENT OF GLYCOCALYX | |
| IN2011KN05169A (en) | ||
| SG194410A1 (en) | Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof | |
| UA97359C2 (en) | Immunogenic composition | |
| NZ626573A (en) | Glutamine enriched nutritional composition for preterm infants | |
| GEP20125563B (en) | 2-amino-2-phenylalkanol derivatives, preparation method thereof and pharmaceutical compositions containing same |